Jeffrey Bennett

Has grant

Professor

University of Denver

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Jeffrey Bennett is a Professor at the University of Colorado Denver, USA. His research primarily focuses on neuromyelitis optica spectrum disorder, investigating its epidemiology, clinical presentations, and therapeutic approaches. His recent publications include studies on the efficacy of Satralizumab, the structural basis of aquaporin-4 autoantibody binding, and the role of B cell activity in disease progression.

Recent Grants

Grant: Close

Humoral Immunity, Astrocyte Injury, and Demyelination in Neuromyelitis Optica

Open Date:

Close Date:

Grant: Close

AQP4 Autoantibodies and Disease Pathogenesis in Neuromyelitis Optica

Open Date:

Close Date:

Articles (11)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Collaborators (5)

Kazuo Fujihara

Professor/MD

Tohoku Daigaku

JAPAN

View details

Meghna Gupta

Assistant Professor

Oregon Health & Science University

UNITED STATES

View details

Brian Weinshenker

Professor

University of Virginia

UNITED STATES

View details

Kevin O'Connor

Associate Professor

Yale University School of Medicine

UNITED STATES

View details

Emily M Mace

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jeffrey Bennett

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (11)

Structural basis of aquaporin-4 autoantibody binding in neuromyelitis optica

Long-Term Efficacy and Safety of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disorder From the SAkuraMoon Open-Label Extension Study

Assessing the Diagnostic Value of Brain White Matter Hyperintensities and Clinical Symptoms in Predicting the Detection of CSF-Venous Fistula in Patients with Suspected Spontaneous Intracranial Hypotension

The epidemiology and clinical presentation of seropositive neuromyelitis optica spectrum disorder in a US population

A Noncanonical CD56dimCD16dim/− NK Cell Subset Indicative of Prior Cytotoxic Activity Is Elevated in Patients with Autoantibody-Mediated Neurologic Diseases

B cell and aquaporin‐4 antibody relationships with neuromyelitis optica spectrum disorder activity

A Randomized Prospective Trial Comparing Repository Corticotropin Injection and Intravenous Methylprednisolone for Neuroprotection in Acute Optic Neuritis

Emerging Principles for Treating Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)

Association between B-cell depletion and attack risk in neuromyelitis optica spectrum disorder: An exploratory analysis from N-MOmentum, a double-blind, randomised, placebo-controlled, multicentre phase 2/3 trial

Serum Glial Fibrillary Acidic Protein: A Neuromyelitis Optica Spectrum Disorder Biomarker

Differential Effects of Fingolimod and Natalizumab on B Cell Repertoires in Multiple Sclerosis Patients

Collaborators (5)

Kazuo Fujihara

Meghna Gupta

Brian Weinshenker

Kevin O'Connor

Emily M Mace

Make your next move.